Jianpi Huayu Prescription Prevents Atherosclerosis by Improving Inflammation and Reshaping the Intestinal Microbiota in ApoE−/− Mice
Cell Biochemistry and Biophysics · 2024
DOI: 10.1007/s12013-024-01341-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Hao-Ran Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: First Affiliated Hospital of Shihezi University, Shihezi, 832000, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Atherosclerosis, Toll-Like Receptor 4, Myeloid Differentiation Factor 88. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation Project, National Administration of Traditional Chinese Medicine young Qhuang scholars support project, Xinjiang Corps key areas of science and technology project.
Abstract (Originalsprache)
This study established an LPS-induced RAW264.7 macrophage inflammatory injury model and an AS mouse vulnerable plaque model to observe the effect of JPHYP on macrophage inflammation, plaque formation, blood lipids, inflammation levels, intestinal flora and the influence of TLR4/MyD88/MAPK pathway, and explore the anti-AS effect and molecular mechanism of JPHYP, and detected 16S rRNA of mice intestinal microbes. The difference of intestinal flora in different groups of mice was compared to further explore the intervention effect of JPHYP and clarify the molecular biological mechanism of JPHYP in preventing and treating AS by regulating TLR4/MyD88/MAPK inflammatory signaling pathway and improving intestinal flora.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Affiliated Hospital of Shihezi University, Shihezi, 832000, China.
- College of pharmacy, Shihezi University, Shihezi, 832000, China.
- First Affiliated Hospital of Shihezi University, Shihezi, 832000, China. haoxin0431@163.com.
- College of pharmacy, Shihezi University, Shihezi, 832000, China. haoxin0431@163.com.
- First Affiliated Hospital of Shihezi University, Shihezi, 832000, China. 912586487@qq.com.
Förderung
- National Natural Science Foundation Project
- National Administration of Traditional Chinese Medicine young Qhuang scholars support project
- Xinjiang Corps key areas of science and technology project
- Shihezi University project
Zitieren
APA
Zhao, H. R., Xian, Q. C., Zhang, X. M., Ma, X. Y., Wang, F. Q., Wang, R. S., Liu, Z. J., & Zhang, Z. G. (2024). Jianpi Huayu Prescription Prevents Atherosclerosis by Improving Inflammation and Reshaping the Intestinal Microbiota in ApoE−/− Mice. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01341-6
Vancouver
Zhao HR, Xian QC, Zhang XM, Ma XY, Wang FQ, Wang RS, et al. Jianpi Huayu Prescription Prevents Atherosclerosis by Improving Inflammation and Reshaping the Intestinal Microbiota in ApoE−/− Mice. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01341-6
BibTeX
@article{Zhao2024,
author = {Zhao, Hao-Ran and Xian, Qin-Chi and Zhang, Xuan-Ming and Ma, Xiao-Yu and Wang, Fu-Qiao and Wang, Rui-Si and Liu, Zhi-Jie and Zhang, Zhi-Gang},
title = {Jianpi Huayu Prescription Prevents Atherosclerosis by Improving Inflammation and Reshaping the Intestinal Microbiota in ApoE−/− Mice},
journal = {Cell Biochemistry and Biophysics},
year = {2024},
doi = {10.1007/s12013-024-01341-6}
}
EUVIMED